Fewer <scp>COVID‐19</scp> Neurological Complications with Dexamethasone and Remdesivir

Abstract

Treatment with dexamethasone, remdesivir, or both in patients hospitalized with COVID-19 was associated with a lower frequency of neurological complications in an additive manner, such that the greatest benefit was observed in patients who received both drugs together. ANN NEUROL 2023;93:88-102.